Fuat Demirelli
-
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Gastric Cancer Management and Outcomes 6
-
- Melanoma and MAPK Pathways 3
-
- Colorectal and Anal Carcinomas 3
-
- Gastrointestinal Tumor Research and Treatment 3
- Co-authors
- Mustafa ÖzgüroğluEvin BüyükünalSüheyla SerdengeçtiNil Molinas MandelGökhan DemirFatih SelçukbırıcıkSibel ErdamarAhmet Bılıcı
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)BMC Cancer (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Fuat Demirelli
31 papers receiving 285 citations
Peers
Comparison fields: 5 of 58
- Oncology 135
- Pathology and Forensic Medicine 83
- Otorhinolaryngology 18
- Reproductive Medicine 30
- Cancer Research 46
Countries citing papers authored by Fuat Demirelli
This map shows the geographic impact of Fuat Demirelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuat Demirelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuat Demirelli more than expected).
Fields of papers citing papers by Fuat Demirelli
This network shows the impact of papers produced by Fuat Demirelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuat Demirelli. The network helps show where Fuat Demirelli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fuat Demirelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 5 | |
| 8 | 2019 | 13 | |
| 9 | 2018 | 2 | |
| 10 | 2015 | 11 | |
| 11 | 2013 | 1 | |
| 12 | 2013 | 6 | |
| 13 | 2005 | 8 | |
| 14 | 2002 | 22 | |
| 15 | 2000 | 25 | |
| 16 | Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study). | 2000 | 4 |
| 17 | 1999 | 21 | |
| 18 | 1999 | 6 | |
| 19 | 1999 | 28 | |
| 20 | 1999 | 7 |
About Fuat Demirelli
Fuat Demirelli is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 296 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Melanoma and MAPK Pathways (3 papers), Colorectal and Anal Carcinomas (3 papers), HER2/EGFR in Cancer Research (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (135 citations), Pathology and Forensic Medicine (83 citations) and Otorhinolaryngology (18 citations). Fuat Demirelli has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Mustafa Özgüroğlu, Evin Büyükünal, Süheyla Serdengeçti, Nil Molinas Mandel, Gökhan Demir, Fatih Selçukbırıcık, Sibel Erdamar, Ahmet Bılıcı, Deniz Tural and Gökhan Demir. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.